Emmaus Medical, INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersTorrance, CA
US patents3
SAM.gov UEIM269WMVERVY4
CAGE code4KN12
Incorporated inDE
- development
- commercialization
- treatments
- therapies
- diseases
- sickle cell disease
- diverticulosis
- reports
- financial condition
Named on the company’s own website, read JUL 29, 2026
CareersCareers page — seen SEP 8, 2026
Supplier designations
For Profit OrganizationManufacturer of GoodsMinority Owned Business
Self-certified by the company in its SAM.gov registration
Patents
3 US patents granted 2017–2022, 1 of them in the five years to SEP 2025.
Pharmaceuticals 3
- Methods and compositions for the treatment of diverticulosisUS 11,304,918 · granted APR 19, 2022
- Methods and compositions for the treatment of diverticulosisUS 10,258,586 · granted APR 16, 2019
- Methods and compositions for the treatment of diverticulosisUS 9,616,041 · granted APR 11, 2017
Granted to Emmaus Medical, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Emmaus Medical, INC | Torrance | CA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.